NYSE$CYH
Community Health Systems Inc · Q4 2021 earnings
Q4 2021 earnings · · Investor relations
Briefing
Announced fourth quarter and year ended December 31, 2021 results
Community Health Systems, Inc. reported a net operating revenue of $3.233 billion for Q4 2021, a 3.7% increase compared to the same period in 2020. Net income attributable to Community Health Systems, Inc. stockholders was $178 million, or $1.34 per share (diluted). Adjusted EBITDA was $540 million, including $46 million of pandemic relief funds.
- Net operating revenues totaled $3.233 billion.
- Net income attributable to Community Health Systems, Inc. stockholders was $178 million, or $1.34 per share (diluted).
- Adjusted EBITDA was $540 million, including $46 million of pandemic relief funds.
- On a same-store basis, admissions decreased 3.9 percent and adjusted admissions increased 1.7 percent, compared with the same period in 2020.
Headline financials
Revenue & EPS history
CHS · Revenue · Quarterly
$3.23B
Forward guidance
The Company’s projections exclude the following: Effect of debt refinancing activities, including gains and losses from early extinguishment of debt; Impairment of goodwill and long-lived assets; Previously recorded pandemic relief funds and the potential recognition of additional pandemic relief funds; The impact of any potential future divestitures; Gains or losses from the sales of businesses; Employee termination benefits and restructuring costs; Resolution of government investigations or other significant legal settlements; Costs incurred in connection with divestitures; and Other significant gains or losses that neither relate to the ordinary course of business nor reflect the Company’s underlying business performance.
Tailwinds
- Net operating revenues (in millions) $ 12,600 to $ 13,100
- Adjusted EBITDA (in millions) $ 1,825 to $ 1,975
- Net income per share - diluted $ 1.00 to $ 1.50
- Weighted-average diluted shares (in millions) 133.0 to 134.0
- Total fixed rate debt is expected to average approximately 100% of total debt during 2022.
Headwinds
- impact of government actions on us, including with respect to vaccine mandates, testing requirements, travel restrictions and other virus containment measures
- changes in net revenue due to patient volumes, payor mix and evolving macroeconomic conditions
- the extent to and manner in which states support increases, decreases or changes in Medicaid programs, implement health insurance exchanges or alter the provision of healthcare to state residents through legislation, regulation or otherwise
- any security breaches, loss of data, actual or perceived failures to comply with legal requirements governing the privacy and security of health information or other regulated, sensitive or confidential information, or legal requirements regarding data privacy or data protection, and other cybersecurity incidents
- any potential impairments in the carrying value of goodwill, other intangible assets, or other long-lived assets, or changes in the useful lives of other intangible assets
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2021
+1.7%
Avg return
Earnings day
+3.6%
Avg return
5 days after
+2.4%
Avg return
30 days after
55%
38 / 69 earnings
Positive
+52.4%
Q4 2022
Best reaction
-41.0%
Q2 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -3.3% | +6.3% | +3.0% | |
| Q4 2025 | +5.7% | +4.5% | -13.5% | |
| Q3 2025 | +25.8% | +29.1% | -4.3% | |
| Q2 2025 | +0.0% | -0.7% | +7.7% | |
| Q1 2025 | +18.5% | +11.1% | +51.0% | |
| Q4 2024 | +7.8% | +9.9% | -22.4% | |
| Q3 2024 | -22.6% | -25.3% | -33.5% | |
| Q2 2024 | +17.5% | +27.9% | +24.9% | |
| Q1 2024 | +9.8% | +11.1% | +20.9% | |
| Q4 2023 | -28.4% | -27.7% | -11.6% | |
| Q3 2023 | -7.0% | -18.0% | +12.1% | |
| Q2 2023 | +11.8% | -8.4% | -18.9% | |
| Q1 2023 | -39.9% | -42.3% | -48.4% | |
| Q4 2022 | +52.4% | +56.3% | -0.6% | |
| Q3 2022 | +36.8% | +35.4% | +68.9% | |
| Q2 2022 | -41.0% | -39.6% | -38.6% | |
| Q1 2022 | -4.2% | -19.1% | -40.1% | |
| Q4 2021 | -10.1% | -21.3% | -15.1% | |
| Q3 2021 | +19.1% | +28.9% | +28.4% | |
| Q2 2021 | -6.4% | -8.3% | -13.1% | |
| Q1 2021 | +0.3% | +15.2% | +37.9% | |
| Q4 2020 | -7.6% | -9.3% | +28.3% | |
| Q3 2020 | +19.2% | +30.3% | +78.3% | |
| Q2 2020 | +14.2% | +26.4% | +37.8% | |
| Q1 2020 | -7.4% | -22.9% | -11.8% | |
| Q4 2019 | +42.7% | +27.8% | -44.2% | |
| Q3 2019 | -17.0% | -30.4% | -32.6% | |
| Q2 2019 | +12.9% | +25.8% | +39.7% | |
| Q1 2019 | -1.7% | -4.0% | -19.9% | |
| Q4 2018 | +12.8% | +21.4% | +8.5% | |
| Q3 2018 | -6.3% | +20.0% | +33.3% | |
| Q2 2018 | +2.3% | +9.5% | +16.7% | |
| Q1 2018 | +34.7% | +26.5% | +8.2% | |
| Q4 2017 | -11.6% | -15.0% | -31.6% | |
| Q3 2017 | -23.1% | -26.6% | -26.3% | |
| Q2 2017 | -7.8% | -8.8% | +6.9% | |
| Q1 2017 | +19.9% | +11.7% | +2.8% | |
| Q4 2016 | +33.8% | +33.6% | +21.7% | |
| Q3 2016 | +0.8% | +4.9% | +3.0% | |
| Q2 2016 | -1.5% | -0.5% | -19.3% | |
| Q1 2016 | -22.1% | — | — | |
| Q4 2015 | -22.1% | — | — | |
| Q3 2015 | -2.4% | — | — | |
| Q2 2015 | +1.2% | — | — | |
| Q1 2015 | -7.6% | — | — | |
| Q4 2014 | +1.2% | — | — | |
| Q3 2014 | -5.0% | — | — | |
| Q2 2014 | -4.9% | — | — | |
| Q1 2014 | -7.2% | — | — | |
| Q4 2013 | +0.3% | — | — | |
| Q3 2013 | -0.3% | — | — | |
| Q2 2013 | +2.2% | — | — | |
| Q1 2013 | +4.7% | — | — | |
| Q4 2012 | +1.4% | — | — | |
| Q3 2012 | +2.4% | — | — | |
| Q2 2012 | -4.3% | — | — | |
| Q1 2012 | +5.2% | — | — | |
| Q4 2011 | +5.3% | — | — | |
| Q3 2011 | -2.7% | — | — | |
| Q2 2011 | -6.4% | — | — | |
| Q1 2010 | -3.5% | — | — | |
| Q1 2011 | +0.1% | — | — | |
| Q4 2008 | +8.0% | — | — | |
| Q4 2010 | +8.0% | — | — | |
| Q3 2009 | +2.0% | — | — | |
| Q3 2010 | +2.0% | — | — | |
| Q4 2009 | +4.3% | — | — | |
| Q2 2009 | +4.3% | — | — | |
| Q2 2010 | +4.3% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro